Tonya McSherry is VP, Sales EMEA, at Oxford Nanopore Technologies with a focus on enabling the technology across the region, impacting both the clinical and applied markets. Tonya started her genomic career supporting the development of a newborn screening test for SCID followed by use of whole genome sequencing to understand complex diseases such as diabetes before supporting the advancement of many large-scale genome studies across Europe. With a passion to see a change in standard of care with genomics, Tonya is dedicated to improving health outcomes and sustainability which will transform today’s society.